Encephalitis and Viral Infection: Mechanisms and Therapies

Dear Colleagues,

This Special Issue offers a platform for researchers to delve into the intricate relationship between neurovirology, encephalitis, and efficient therapies. Neurovirology and encephalitis are complex and often intertwined fields that are informative to the gene therapy field for treating neurologic diseases. In addition, recent advancements in gene therapies have opened new avenues for understanding and treating these encephalitic and neurologic diseases. This Special Issue acts as a bridge, fostering interdisciplinary collaboration and advancing medical knowledge.

We invite original research articles and reviews that contribute to the understanding of the following aspects within the scope of this Special Issue:

Neurovirology: Investigations into the molecular mechanisms underlying neurotropic viral infections, their impact on neural function, and the development of antiviral strategies.

Encephalitis: Studies on the etiology, pathogenesis, diagnosis, and management of encephalitis, with a focus on both infectious and autoimmune forms.

Gene therapy: Research on the development and application of gene therapies for neurologic diseases, including the use of viral vectors, gene editing techniques, and immunomodulatory approaches.

Interdisciplinary approaches: Contributions that bridge the gap between neurovirology, encephalitis, and gene therapies, offering novel insights, therapeutic strategies, and potential translational applications.

By bringing together experts from these diverse fields, this Special Issue seeks to foster collaboration, stimulate innovative research, and ultimately contribute to the development of novel therapeutic interventions for neuroviral infections, encephalitis, and neurologic diseases. We welcome manuscripts that explore the intersections of these disciplines, providing a holistic view of the challenges and opportunities in this critical area of biomedical science.

Dr. Bradley S. Hollidge
Dr. Samantha S. Soldan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• neurovirology
• encephalitis
• gene therapy
• viral vectors
• virology
• immunology
• neuroscience
• gene editing